SMAD4 and pancreatic neoplasm: As shown in Table 1, the tumor suppressor Smad4, also known as dpc4 (deleted in pancreatic cancer), is particularly affected by these genetic alterations, being mutated or deleted in no less than half of human pancreatic cancer, where it was originally characterized [141].